BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16299354)

  • 1. Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.
    Wilusz JE; Devanney SC; Caputi M
    Nucleic Acids Res; 2005; 33(20):6547-54. PubMed ID: 16299354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
    Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
    Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
    Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
    Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.
    Taylor JK; Zhang QQ; Wyatt JR; Dean NM
    Nat Biotechnol; 1999 Nov; 17(11):1097-100. PubMed ID: 10545916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
    Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
    J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bcl-xL expression by antisense oligonucleotides containing various bridged nucleic acids (BNAs).
    Roongjang S; Takahashi K; Obika S; Imanishi T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):113-4. PubMed ID: 18029612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.
    DeOcesano-Pereira C; Amaral MS; Parreira KS; Ayupe AC; Jacysyn JF; Amarante-Mendes GP; Reis EM; Verjovski-Almeida S
    Nucleic Acids Res; 2014 Jul; 42(13):8343-55. PubMed ID: 24992962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
    Dou Z; Lei H; Su W; Zhang T; Chen X; Yu B; Zhen X; Si J; Sun C; Zhang H; Di C
    Cell Death Dis; 2024 Feb; 15(2):160. PubMed ID: 38383492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
    Liu Y; Braasch DA; Nulf CJ; Corey DR
    Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.
    Stevens M; Oltean S
    Front Genet; 2019; 10():804. PubMed ID: 31552099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
    Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of TdT Expression through Splicing Modulation by Antisense Peptide Nucleic Acid (PNA).
    Montazersaheb S; Kazemi M; Nabat E; Nielsen PE; Hejazi MS
    Curr Pharm Biotechnol; 2019; 20(2):168-178. PubMed ID: 30727883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering splicing factors with designed specificities.
    Wang Y; Cheong CG; Hall TM; Wang Z
    Nat Methods; 2009 Nov; 6(11):825-30. PubMed ID: 19801992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular delivery and antisense effects of peptide nucleic acid conjugated to polyethyleneimine via disulfide linkers.
    Berthold PR; Shiraishi T; Nielsen PE
    Bioconjug Chem; 2010 Oct; 21(10):1933-8. PubMed ID: 20873710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.
    Mologni L; Nielsen PE; Gambacorti-Passerini C
    Biochem Biophys Res Commun; 1999 Oct; 264(2):537-43. PubMed ID: 10529398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
    Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
    Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA.
    Boutimah-Hamoudi F; Leforestier E; Sénamaud-Beaufort C; Nielsen PE; Giovannangeli C; Saison-Behmoaras TE
    Nucleic Acids Res; 2007; 35(12):3907-17. PubMed ID: 17537815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells.
    Wu L; Mao C; Ming X
    Biomed Res Int; 2016; 2016():7478650. PubMed ID: 27579319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.
    Willimott S; Merriam T; Wagner SD
    Biochem Biophys Res Commun; 2011 Feb; 405(3):480-5. PubMed ID: 21256112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.